Latest development4 months ago
DexCom Wins FDA Clearance for Stelo Glucose Sensor Pediatric Use
The FDA has cleared DexCom's Stelo OTC biosensor for children aged 2 and older, expanding the device's reach beyond the adult market.
Read the full story
DexCom's over-the-counter continuous glucose monitor, Stelo, has received FDA clearance for pediatric use in children aged 2 years and older. This strategic expansion allows children who do not use insulin to access real-time glucose monitoring through the Stelo biosensor. The approval, finalized in mid-June, broadens the market reach for DexCom’s non-prescription glucose monitoring technology.
The FDA has cleared DexCom's Stelo OTC biosensor for children aged 2 and older, expanding the device's reach beyond the adult market.
Read the full storyThe FDA has cleared Dexcom's over-the-counter Stelo glucose monitor for children aged 2 and older, significantly expanding its market reach.
DexCom's over-the-counter Stelo CGM has received regulatory approval for pediatric use, expanding access to glucose monitoring technology for younger populations.